Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer

Radiotherapy and Oncology

Volumn 95, Issue 3, 2010, Pages 350-358

  Hurwitz, Mark D ^a   Kaur, Punit ^b   Nagaraja, Ganachari M ^b   Bausero, Maria A ^b   Manola, Judith ^a   Asea, Alexzander ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Texas A and M Health Sciences Center   (United States)

Author keywords

Androgen suppressive therapy; Chaperokine; Heat shock proteins; Prostate cancer; Radiation

Indexed keywords

ANTIANDROGEN; HEAT SHOCK PROTEIN 72; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANDROGEN THERAPY; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; EXOSOME; GAMMA IRRADIATION; HUMAN; HUMAN CELL; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; EXOSOMES; HSP27 HEAT-SHOCK PROTEINS; HSP72 HEAT-SHOCK PROTEINS; HUMANS; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED BALB C; PROSTATIC NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77952583449     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.03.024     Document Type: Article

References (33)

1. Beckmann R.P., Mizzen L.E., and Welch W.J. Interaction of Hsp 70 with newly synthesized proteins: implications for protein folding and assembly. Science 248 (1990) 850-854
2. Gething M.J., and Sambrook J. Protein folding in the cell. Nature 355 (1992) 33-45
3. Gyrd-Hansen M., Nylandsted J., and Jaattela M. Heat shock protein 70 promotes cancer cell viability by safeguarding lysosomal integrity. Cell Cycle 3 (2004) 1484-1485
4. Netzer W.J., and Hartl F.U. Protein folding in the cytosol: chaperonin-dependent and -independent mechanisms. Trends Biochem Sci 23 (1998) 68-73
5. Nylandsted J., Brand K., and Jaattela M. Heat shock protein 70 is required for the survival of cancer cells. Ann NY Acad Sci 926 (2000) 122-125
6. Nylandsted J., Rohde M., Brand K., Bastholm L., Elling F., and Jaattela M. Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2. Proc Natl Acad Sci USA 97 (2000) 7871-7876
7. Srivastava P.K., and Maki R.G. Stress-induced proteins in immune response to cancer. Curr Topics Microbiol and Immunol 167 (1991) 109-123
8. Udono H., Levey D.L., and Srivastava P.K. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo. Proc Natl Acad Sci USA 91 (1994) 3077-3081
9. Udono H., and Srivastava P.K. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J Immunol 152 (1994) 5398-5403
10. Udono H., and Srivastava P.K. Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 178 (1993) 1391-1396
11. Breloer M., Fleischer B., and von Bonin A. In vivo and in vitro activation of T cells after administration of Ag- negative heat shock proteins. J Immunol 162 (1999) 3141-3147
12. Asea A., Kabingu E., Stevenson M.A., and Calderwood S.K. HSP70 peptide-bearing and peptide-negative preparations act as chaperokines. Cell Stress Chaperones 5 (2000) 425-431
13. Asea A., Kraeft S.K., Kurt-Jones E.A., Stevenson M.A., Chen L.B., Finberg R.W., et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 6 (2000) 435-442
14. Asea A., Rehli M., Kabingu E., Boch J.A., Bare O., Auron P.E., et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277 (2002) 15028-15034
15. Botzler C., Li G., Issels R.D., and Multhoff G. Definition of extracellular localized epitopes of Hsp70 involved in an NK immune response. Cell Stress Chaperones 3 (1998) 6-11
16. Multhoff G., Botzler C., Wiesnet M., Muller E., Meier T., Wilmanns W., et al. A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells. Int J Cancer 61 (1995) 272-279
17. Ciocca D.R., and Calderwood S.K. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10 (2005) 86-103
18. Cornford P.A., Dodson A.R., Parsons K.F., Desmond A.D., Woolfenden A., Fordham M., et al. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 60 (2000) 7099-7105
19. Abe M., Manola J.B., Oh W.K., Parslow D.L., George D.J., Austin C.L., et al. Plasma levels of heat shock protein 70 in patients with prostate cancer: a potential biomarker for prostate cancer. Clin Prostate Cancer 3 (2004) 49-53
20. Buccellato L.J., Tso M., Akinci O.I., Chandel N.S., and Budinger G.R. Reactive oxygen species are required for hyperoxia-induced Bax activation and cell death in alveolar epithelial cells. J Biol Chem 279 (2004) 6753-6760
21. Bausero M.A., Gastpar R., Multhoff G., and Asea A. Alternative mechanism by which IFN-gamma enhances tumor recognition: active release of heat shock protein 72. J Immunol 175 (2005) 2900-2912
22. Pockley A.G., De Faire U., Kiessling R., Lemne C., Thulin T., and Frostegard J. Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J Hypertens 20 (2002) 1815-1820
23. Wubbolts R., Leckie R.S., Veenhuizen P.T., Schwarzmann G., Mobius W., Hoernschemeyer J., et al. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem 278 (2003) 10963-10972
24. Savina A., Furlan M., Vidal M., and Colombo M.I. Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem 278 (2003) 20083-20090
25. Bausero M.A., Bharti A., Page D.T., Perez K.D., Eng J.W., Ordonez S.L., et al. Silencing the hsp25 gene eliminates migration capability of the highly metastatic murine 4T1 breast adenocarcinoma cell. Tumour Biol 27 (2006) 17-26
26. Bausero M.A., Page D.T., Osinaga E., and Asea A. Surface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasis. Tumour Biol 25 (2004) 243-251
27. Asea A. Hsp70: a chaperokine. Novartis Found Symp 291 (2008) 173-179 (discussion 179-183, 221-174)
28. Asea A. Initiation of the immune response by extracellular Hsp72: chaperokine activity of Hsp72. Curr Immunol Rev 2 (2006) 209-215
29. Asea A. Stress proteins and initiation of immune response: chaperokine activity of hsp72. Exerc Immunol Rev 11 (2005) 34-45
30. Lancaster G.I., and Febbraio M.A. Exosome-dependent trafficking of HSP70: a novel secretory pathway for cellular stress proteins. J Biol Chem 280 (2005) 23349-23355
31. Fleshner M., Campisi J., Amiri L., and Diamond D.M. Cat exposure induces both intra- and extracellular Hsp72: the role of adrenal hormones. Psychoneuroendocrinology 29 (2004) 1142-1152
32. Zitvogel L., Regnault A., Lozier A., Wolfers J., Flament C., Tenza D., et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 4 (1998) 594-600
33. Mignot G., Roux S., Thery C., Segura E., and Zitvogel L. Prospects for exosomes in immunotherapy of cancer. J Cell Mol Med 10 (2006) 376-388